Healthcare Reform Legislation: New Drug Sample Reporting Requirement Packs 3 Compliance Concerns
HHS' ability to track drug samples ups the risks for doctors.
Picture this: Health & Human Services' OIG inspectors arrive at a physician office with a list of all the drug samples that the physician has received from pharma companies over the past two years. And they want to cross check the information against the physician's records and billing.
That scenario could become reality once a healthcare reform legislation provision goes into effect. Starting in 2012, drug companies will have to inform HHS annually what drug samples they gave to which physicians.Details required: The company will report in...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: